Treatment with IL33 attenuated diet-induced hepatic steatosis, and this effect may be due to the promotional effect of IL33 on Th2 response and M2 macrophage activation in mice exposed to a high-fat diet or an MCD diet [63,64]. This evidence concerns the gene IL33 and fatty liver disease.